Corporate Finance

A new clinical trial is testing a device that uses electricity to deliver chemo directly into tumors, a strategy that could revolutionize treatment.

UC Irvine and Konnect partner on a new certification to equip senior HR leaders with the strategic skills needed to navigate the AI revolution.

Mars is transforming its historic Slough chocolate factory with AI and robotics, signaling a major vote of confidence in the UK's manufacturing future.

Profitable and capital-efficient, the HR platform is using its Series B to scale its integrated payroll and finance solution in the US and Europe.

Led by OrbiMed, the financing will propel Accro's promising oral RIPK2 inhibitor for Ulcerative Colitis into a pivotal Phase IIb clinical trial.

Hormel Foods declared its 392nd dividend, but a high payout ratio and lagging stock have investors weighing its legendary reliability against current risks.

As graphene leader NanoXplore appoints CEO Rocco Marinaccio to its board, the move signals a push for faster growth but raises timeless governance questions.

Activist investor BIMIZCI launches a proxy fight, citing a CEO's fraud judgment and 'flip phone' era technology in a battle for Medallion's future.

New projects leverage AI, gene therapy advances, and diverse workforce initiatives to bolster America's manufacturing and secure its talent pipeline.

EcoShield Pest Solutions combines a nationwide push-up challenge with donations to support Wounded Warrior Project, fostering a unique corporate culture.

As marketers demand smarter analytics, Upwave hires industry veteran John Bulgrin as CRO to accelerate its AI-powered brand outcomes measurement platform.

With a fresh $170M in funding, RADAR is equipping brick-and-mortar stores with e-commerce level intelligence, aiming to redefine the future of shopping.

Dubai-based robotics firm Micropolis AI is under scrutiny after a delayed annual report triggered a warning from the NYSE American exchange.

The P2P texting pioneer is now employee-owned, a strategic move poised to reshape campaign tech and champion authentic connection in the 2026 midterms.

Newly independent, auto supplier Versigent will meet investors to prove its critical role in powering the EV and autonomous vehicle revolution.

In a major private equity shuffle, IMA Financial secures a $4B valuation, fueling growth while keeping its 3,000+ associates as majority owners.

With a novel two-in-one device and a $41M funding boost, Cagent Vascular is poised to challenge the standard of care for complex calcified arteries.

A new Silicon Valley facility will use advanced robots to turn mountains of paper into the high-quality data that artificial intelligence desperately needs.

Nourish lands $100M to expand its AI-powered metabolic clinic, blending dietitian care with technology to reverse chronic disease and cut healthcare costs.

With $500K in new funding, snack startup B-SIDES is bringing its 90s-inspired, upcycled puffs from online success to over 1,500 retail stores.